Professional Documents
Culture Documents
doi:
10.11607/jomi.4149.
Author information:
(1)Department of Diagnosis and Surgery, School of Dentistry at Araraquara,
Universidade Estadual Paulista, UNESP, Sao Paulo, Brazil.
(2)Assistant Professor, Department of Diagnosis and Surgery, School of Dentistry
at Araraquara, Universidade Estadual Paulista, UNESP, Humaita, 1680, Zipcode:
14801-903 Araraquara/Sao Paulo, Brazil, Phone: +55 16 33016508 e-mail:
danielalzandim@foar.unesp.br.
4. Clin Oral Implants Res. 2015 Sep;26 Suppl 11:15-44. doi: 10.1111/clr.12636.
Author information:
(1)Department of Oral Health Sciences, Kristianstad University, Kristianstad,
Sweden.
(2)School of Dental Sciences, Trinity College, Dublin, Ireland.
(3)Blekinge Institute of Technology, Karlskrona, Sweden.
(4)Department of Oral Health Sciences, Katholieke Universiteit Leuven, University
Hospitals Leuven, Leuven, Belgium.
2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DOI: 10.1111/clr.12636
PMID: 26385619 [Indexed for MEDLINE]
3.
Author information:
(1)Faculty of Odontology, University of Seville, Seville, Spain.
DOI: 10.1902/jop.2015.150229
PMID: 26334497 [Indexed for MEDLINE]
Darby I(1).
Author information:
(1)Melbourne Dental School, The University of Melbourne, Victoria, Australia.
In the next few years there will be a great increase in the percentage of the
population aged over 65. Not only will they have more teeth than previous
generations, but also a large number of implants. The increase in age is
accompanied by an increase in the prevalence and incidence of periodontal
diseases. In addition, there is a decrease in manual dexterity and an increase in
co-morbidity and medications affecting the oral cavity. Dental care in aged care
facilities can be poor and access to dental professionals difficult. This article
discusses these issues.
DOI: 10.1111/adj.12280
PMID: 25762038 [Indexed for MEDLINE]
8. Clin Oral Implants Res. 2016 Feb;27(2):156-61. doi: 10.1111/clr.12552. Epub 2015
Jan 26.
Author information:
(1)Department of Pharmacological Research in Dentistry, Faculty of Dentistry,
University of Granada, Granada, Spain.
(2)Department of Implant Dentistry, Master of Implant Dentistry and Biomaterials,
School of Medicine and Dentistry, University of Murcia, Murcia, Spain.
(3)Department of Periodontology, Master of Periodontology and Implant Dentistry,
Faculty of Dentistry, University of Granada, Granada, Spain.
(4)School of Dental Medicine, Stony Brook University, Stony Brook, NY, USA.
(5)Department of Special Care in Dentistry, Pharmacological Research in
Dentistry, Master of Periodontology and Implant Dentistry, Faculty of Dentistry,
University of Granada, Granada, Spain.
OBJECTIVES: The aim of this study was to evaluate implant survival and primary
stability parameters in patients with diabetes with different levels of
glycosylated hemoglobin Alc (HbA1c) treated with immediate placement and
provisionalization of implant-supported, single-tooth replacements over 2 years.
MATERIALS AND METHODS: Eighty-five patients were divided into three groups
according to their HbA1c levels: 33 patients in Group 1 (<6, control group); 30
patients in Group 2 (6.1-8); and 22 patients in Group 3 (8.1-10). Each patient
received one-one-piece implant in the anterior zone of the upper maxillary. The
implant survival rate was analyzed for each group, together with three variables
to evaluate the general state of peri-implant health: probe depth, bleeding on
probing, marginal bone loss.
RESULTS: Marginal bone loss increased in relation with higher HbA1c levels. For
marginal bone loss in Group 1, mean resorption values ranged from 0.51 after
6 months to 0.72 after 2 years in comparison with respective values of 1.33 and
1.92 in Group 3. This pattern was repeated for bleeding on probing, both
parameters showing significant differences between groups. For bleeding on
probing, mean bleeding levels varied from 0.36 in Group I at 6 months after
implant placement, to 0.59 in Group 3 (P = 0.041 between the three groups).
Peri-implant pocket depth showed the same tendency to increase in relation to
HbA1C but differences between groups did not reach statistical significance.
CONCLUSIONS: Patients with diabetes can receive implant-based treatments with
immediate loading safely, providing they present moderate HbA1c values.
2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DOI: 10.1111/clr.12552
PMID: 25623884 [Indexed for MEDLINE]
Prevalence and predictive factors for peri-implant disease and implant failure: a
cross-sectional analysis.
Author information:
(1)Department of Periodontics, University of Washington, Seattle, Washington.
DOI: 10.1902/jop.2014.140438
PMID: 25415249 [Indexed for MEDLINE]
Author information:
(1)Northern Hessia Implant Center, Hofgeismar, Germany.
2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DOI: 10.1111/jcpe.12298
PMID: 25138992 [Indexed for MEDLINE]
11. Clin Oral Implants Res. 2015 Sep;26(9):1031-5. doi: 10.1111/clr.12391. Epub
2014
Mar 31.
Author information:
(1)Department of Special Care in Dentistry, Pharmacological Research in
Dentistry, Periodontology and Implant Dentistry, Faculty of Dentistry, University
of Granada, Granada, Spain.
(2)Department of Pharmacological Research in Dentistry, Faculty of Dentistry,
University of Granada, Granada, Spain.
(3)Periodontology and Implant Dentistry, Faculty of Dentistry, Universidad de
Granada, Granada, Spain.
(4)Department of Dentistry, Faculty of Dentistry, Universitat Internacional de
Catalunya, Barcelona, Spain.
(5)Department of Implant Dentistry, Implant Dentistry and Biomaterials, School of
Medicine and Dentistry, University of Murcia, Murcia, Spain.
OBJECTIVE: The aim of this study was to analyze the changes produced in
peri-implant tissues in type 2 diabetes mellitus patients with different glycemia
levels, measured by monitoring glycated hemoglobin A1c (HbA1c), over a period of
3 years following dental implant placement.
MATERIALS AND METHODS: Sixty-seven patients were divided into four groups
according to their HbA1c levels: 21 patients in Group 1 (<6); 24 patients in
Group 2 (6.1-8); and 11 patients in Group 3 (8.1-10) and Group 4 (>10.1). Each
patient received one implant. All implants were placed in the anterior zone of
the maxilla. The variables selected to assess the general state of patients'
peri-implant health were as follows: probing depth, bleeding on probing, and
marginal bone loss.
RESULTS: Marginal bone loss was found to increase in relation to increases in
HbA1c levels. Bleeding on probing showed statistically significant differences
between groups. When the peri-implant area was probed, mean levels of bleeding
varied from 0.43 in Group 1 at 1 year after implant surgery to 0.62 in Group 4
(P = 0.042 between the four study groups). After the second year, greater
bleeding on probing was observed in Group 4 (0.63) in comparison with groups with
lower HbA1c levels. Peri-implant pocket depths presented values that were too low
to be considered pathological and without statistically significant differences
between the study groups.
CONCLUSION: Implant therapies for diabetic patients can be predictable, providing
these patients fall within controlled ranges of glycemia over time, assessed by
monitoring HbA1c levels.
2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DOI: 10.1111/clr.12391
PMID: 24684438 [Indexed for MEDLINE]
DOI: 10.1902/jop.2013.134001
PMID: 23537178 [Indexed for MEDLINE]